New Delhi, The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission …
DCGI approves Phase 2,3 clinical trial of Covaxin in the age group of 2 to 18 Years Read More
The Samikhsya Bureau NEW DELHI: Prime Minister Narendra Modi has called the DCGI approval of Serum Institute of India and Bharat Biotech vaccines a decisive turning point to strengthen a …
PM Modi congratulates the Nation on vaccine approval Read MoreNew Delhi: The Drugs Controller General of India (DCGI) has given approval to Pune’s Serum Institute of India (SII) to conduct clinical trials of Oxford University-Astra Zeneca COVID-19 vaccine in India. …
Serum Institute gets DCGI nod for clinical trials of Oxford vax Read More
Mumbai: Drug maker Cipla Ltd. on Friday said it has received regulatory approval from Drug Controller General of India (DCGI) for the launch of Favipiravir in the country under the brand …
Cipla gets DCGI nod to sell Favipiravir under brand ‘Ciplenza’ Read More
